aluates Reports

$ 0.0

Automative

Global Digital Biomarker Market Research Report 2026

Published Date: 2026-04-02

Report Code: QYRE-Auto-6Y6173

Global Digital Biomarker Market Insights and Forecast to 2028

BUY CHAPTERS

Global Digital Biomarker Market Research Report 2026

Code: QYRE-Auto-6Y6173

Report

2026-04-02

Pages:134

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Pfizer Inc

Roche

Sanofi

Philips

Johnson & Johnson

GE Healthcare

Apple

GlaxoSmithKline PLC

Bayer

Merck

Abbott Laboratories

Asahi Kasei

Biogen

Koneksa Health

Huma Therapeutics

Digital Biomarker Market Size

The global Digital Biomarker market was valued at US$ 3619 million in 2025 and is anticipated to reach US$ 233280 million by 2032, at a CAGR of 82.5% from 2026 to 2032.

Digital Biomarker Market

Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.

Digital biomarkers refer to biomedical data collected and analyzed through digital technology, which are used to detect, monitor and predict disease biomarkers. These data are usually collected through technologies such as smart devices, wearable sensors, and mobile applications, including physiological data such as heart rate, gait, blood sugar, brain waves, and sleep patterns. In recent years, with the rapid development of technologies such as artificial intelligence, big data analysis, and the Internet of Things (IoT), digital biomarkers have gradually shown great potential in disease diagnosis, efficacy evaluation, and health management.

At present, the digital biomarker market is in a rapid development stage. The popularity of digital health devices and the demand for personalized medicine and precision medicine have promoted the research and application of digital biomarkers. In the early diagnosis and monitoring of some chronic disease management and neurodegenerative diseases (such as Alzheimer's disease and Parkinson's disease), digital biomarkers have shown significant application value. In addition, digital biomarkers are also playing an increasingly important role in the drug development process, especially in the recruitment of patients in clinical trials, monitoring of treatment effects, and evaluation of side effects.

In the future, digital biomarkers are expected to be more widely used in multiple fields. First, with the continuous advancement of artificial intelligence and machine learning algorithms, the analytical capabilities of digital biomarkers will become more accurate and efficient, which will help to formulate more personalized treatment plans. Secondly, with the popularization of 5G technology, the improvement of real-time data transmission capabilities will enable digital biomarkers to monitor patients' health status in real time and increase the possibility of early detection of diseases. In addition, cross-industry cooperation and standardization of digital biomarkers will also promote their widespread application around the world.

Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.

This report delivers a comprehensive overview of the global Digital Biomarker market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Digital Biomarker. The Digital Biomarker market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Digital Biomarker market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Digital Biomarker manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Digital Biomarker Market Report

Report Metric	Details
Report Name	Digital Biomarker Market
Accounted market size in 2025	US$ 3619 million
Forecasted market size in 2032	US$ 233280 million
CAGR	82.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Passive Digital Biomarker Active Digital Biomarker
Segment by Application	Clinical Disease Daily Health
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Philips, Johnson & Johnson, Pfizer, GE Healthcare, Novartis, Apple, Sanofi, GlaxoSmithKline, Bayer, Merck, Abbott Laboratories, Asahi Kasei, Biogen, Koneksa Health, Roche, Huma Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Digital Biomarker companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Digital Biomarker Market growing?

Ans: The Digital Biomarker Market witnessing a CAGR of 82.5% during the forecast period 2026-2032.

What is the Digital Biomarker Market size in 2032?

Ans: The Digital Biomarker Market size in 2032 will be US$ 233280 million.

What is the market share of major companies in Digital Biomarker Market?

Ans: Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share.

What is the Digital Biomarker Market share by type?

Ans: In terms of type, passive digital biomarker segment holds an important share of about 65%.

What is the Digital Biomarker Market share by application?

Ans: In terms of application, clinical disease segment accounts for about 80% of the total share.

Who are the main players in the Digital Biomarker Market report?

Ans: The main players in the Digital Biomarker Market are Philips, Johnson & Johnson, Pfizer, GE Healthcare, Novartis, Apple, Sanofi, GlaxoSmithKline, Bayer, Merck, Abbott Laboratories, Asahi Kasei, Biogen, Koneksa Health, Roche, Huma Therapeutics

What are the Application segmentation covered in the Digital Biomarker Market report?

Ans: The Applications covered in the Digital Biomarker Market report are Clinical Disease, Daily Health

What are the Type segmentation covered in the Digital Biomarker Market report?

Ans: The Types covered in the Digital Biomarker Market report are Passive Digital Biomarker, Active Digital Biomarker

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Digital Biomarker Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Passive Digital Biomarker

1.2.3 Active Digital Biomarker

1.3 Market by Application

1.3.1 Global Digital Biomarker Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Clinical Disease

1.3.3 Daily Health

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Digital Biomarker Market Perspective (2021–2032)

2.2 Global Digital Biomarker Growth Trends by Region

2.2.1 Global Digital Biomarker Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Digital Biomarker Historic Market Size by Region (2021–2026)

2.2.3 Digital Biomarker Forecasted Market Size by Region (2027–2032)

2.3 Digital Biomarker Market Dynamics

2.3.1 Digital Biomarker Industry Trends

2.3.2 Digital Biomarker Market Drivers

2.3.3 Digital Biomarker Market Challenges

2.3.4 Digital Biomarker Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Digital Biomarker Players by Revenue

3.1.1 Global Top Digital Biomarker Players by Revenue (2021–2026)

3.1.2 Global Digital Biomarker Revenue Market Share by Players (2021–2026)

3.2 Global Top Digital Biomarker Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Digital Biomarker Revenue

3.4 Global Digital Biomarker Market Concentration Ratio

3.4.1 Global Digital Biomarker Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Digital Biomarker Revenue in 2025

3.5 Global Key Players of Digital Biomarker Head Offices and Areas Served

3.6 Global Key Players of Digital Biomarker, Products and Applications

3.7 Global Key Players of Digital Biomarker, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Digital Biomarker Breakdown Data by Type

4.1 Global Digital Biomarker Historic Market Size by Type (2021–2026)

4.2 Global Digital Biomarker Forecasted Market Size by Type (2027–2032)

5 Digital Biomarker Breakdown Data by Application

5.1 Global Digital Biomarker Historic Market Size by Application (2021–2026)

5.2 Global Digital Biomarker Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Digital Biomarker Market Size (2021–2032)

6.2 North America Digital Biomarker Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Digital Biomarker Market Size by Country (2021–2026)

6.4 North America Digital Biomarker Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Digital Biomarker Market Size (2021–2032)

7.2 Europe Digital Biomarker Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Digital Biomarker Market Size by Country (2021–2026)

7.4 Europe Digital Biomarker Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Digital Biomarker Market Size (2021–2032)

8.2 Asia-Pacific Digital Biomarker Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Digital Biomarker Market Size by Region (2021–2026)

8.4 Asia-Pacific Digital Biomarker Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Digital Biomarker Market Size (2021–2032)

9.2 Latin America Digital Biomarker Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Digital Biomarker Market Size by Country (2021–2026)

9.4 Latin America Digital Biomarker Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Digital Biomarker Market Size (2021–2032)

10.2 Middle East & Africa Digital Biomarker Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Digital Biomarker Market Size by Country (2021–2026)

10.4 Middle East & Africa Digital Biomarker Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Philips

11.1.1 Philips Company Details

11.1.2 Philips Business Overview

11.1.3 Philips Digital Biomarker Introduction

11.1.4 Philips Revenue in Digital Biomarker Business (2021–2026)

11.1.5 Philips Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Digital Biomarker Introduction

11.2.4 Johnson & Johnson Revenue in Digital Biomarker Business (2021–2026)

11.2.5 Johnson & Johnson Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Digital Biomarker Introduction

11.3.4 Pfizer Revenue in Digital Biomarker Business (2021–2026)

11.3.5 Pfizer Recent Development

11.4 GE Healthcare

11.4.1 GE Healthcare Company Details

11.4.2 GE Healthcare Business Overview

11.4.3 GE Healthcare Digital Biomarker Introduction

11.4.4 GE Healthcare Revenue in Digital Biomarker Business (2021–2026)

11.4.5 GE Healthcare Recent Development

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Digital Biomarker Introduction

11.5.4 Novartis Revenue in Digital Biomarker Business (2021–2026)

11.5.5 Novartis Recent Development

11.6 Apple

11.6.1 Apple Company Details

11.6.2 Apple Business Overview

11.6.3 Apple Digital Biomarker Introduction

11.6.4 Apple Revenue in Digital Biomarker Business (2021–2026)

11.6.5 Apple Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Digital Biomarker Introduction

11.7.4 Sanofi Revenue in Digital Biomarker Business (2021–2026)

11.7.5 Sanofi Recent Development

11.8 GlaxoSmithKline

11.8.1 GlaxoSmithKline Company Details

11.8.2 GlaxoSmithKline Business Overview

11.8.3 GlaxoSmithKline Digital Biomarker Introduction

11.8.4 GlaxoSmithKline Revenue in Digital Biomarker Business (2021–2026)

11.8.5 GlaxoSmithKline Recent Development

11.9 Bayer

11.9.1 Bayer Company Details

11.9.2 Bayer Business Overview

11.9.3 Bayer Digital Biomarker Introduction

11.9.4 Bayer Revenue in Digital Biomarker Business (2021–2026)

11.9.5 Bayer Recent Development

11.10 Merck

11.10.1 Merck Company Details

11.10.2 Merck Business Overview

11.10.3 Merck Digital Biomarker Introduction

11.10.4 Merck Revenue in Digital Biomarker Business (2021–2026)

11.10.5 Merck Recent Development

11.11 Abbott Laboratories

11.11.1 Abbott Laboratories Company Details

11.11.2 Abbott Laboratories Business Overview

11.11.3 Abbott Laboratories Digital Biomarker Introduction

11.11.4 Abbott Laboratories Revenue in Digital Biomarker Business (2021–2026)

11.11.5 Abbott Laboratories Recent Development

11.12 Asahi Kasei

11.12.1 Asahi Kasei Company Details

11.12.2 Asahi Kasei Business Overview

11.12.3 Asahi Kasei Digital Biomarker Introduction

11.12.4 Asahi Kasei Revenue in Digital Biomarker Business (2021–2026)

11.12.5 Asahi Kasei Recent Development

11.13 Biogen

11.13.1 Biogen Company Details

11.13.2 Biogen Business Overview

11.13.3 Biogen Digital Biomarker Introduction

11.13.4 Biogen Revenue in Digital Biomarker Business (2021–2026)

11.13.5 Biogen Recent Development

11.14 Koneksa Health

11.14.1 Koneksa Health Company Details

11.14.2 Koneksa Health Business Overview

11.14.3 Koneksa Health Digital Biomarker Introduction

11.14.4 Koneksa Health Revenue in Digital Biomarker Business (2021–2026)

11.14.5 Koneksa Health Recent Development

11.15 Roche

11.15.1 Roche Company Details

11.15.2 Roche Business Overview

11.15.3 Roche Digital Biomarker Introduction

11.15.4 Roche Revenue in Digital Biomarker Business (2021–2026)

11.15.5 Roche Recent Development

11.16 Huma Therapeutics

11.16.1 Huma Therapeutics Company Details

11.16.2 Huma Therapeutics Business Overview

11.16.3 Huma Therapeutics Digital Biomarker Introduction

11.16.4 Huma Therapeutics Revenue in Digital Biomarker Business (2021–2026)

11.16.5 Huma Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Pfizer Inc

Roche

Sanofi

Philips

Johnson & Johnson

GE Healthcare

Apple

GlaxoSmithKline PLC

Bayer

Merck

Abbott Laboratories

Asahi Kasei

Biogen

Koneksa Health

Huma Therapeutics

List of Tables

Table 1. Global Digital Biomarker Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Passive Digital Biomarker

Table 3. Key Players of Active Digital Biomarker

Table 4. Global Digital Biomarker Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Digital Biomarker Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Digital Biomarker Market Size by Region (US$ Million), 2021–2026

Table 7. Global Digital Biomarker Market Share by Region (2021–2026)

Table 8. Global Digital Biomarker Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Digital Biomarker Market Share by Region (2027–2032)

Table 10. Digital Biomarker Market Trends

Table 11. Digital Biomarker Market Drivers

Table 12. Digital Biomarker Market Challenges

Table 13. Digital Biomarker Market Restraints

Table 14. Global Digital Biomarker Revenue by Players (US$ Million), 2021–2026

Table 15. Global Digital Biomarker Market Share by Players (2021–2026)

Table 16. Global Top Digital Biomarker Players by Tier (Tier 1, Tier 2, and Tier 3), based on Digital Biomarker Revenue, 2025

Table 17. Ranking of Global Top Digital Biomarker Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Digital Biomarker Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Digital Biomarker, Headquarters and Area Served

Table 20. Global Key Players of Digital Biomarker, Products and Applications

Table 21. Global Key Players of Digital Biomarker, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Digital Biomarker Market Size by Type (US$ Million), 2021–2026

Table 24. Global Digital Biomarker Revenue Market Share by Type (2021–2026)

Table 25. Global Digital Biomarker Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Digital Biomarker Revenue Market Share by Type (2027–2032)

Table 27. Global Digital Biomarker Market Size by Application (US$ Million), 2021–2026

Table 28. Global Digital Biomarker Revenue Market Share by Application (2021–2026)

Table 29. Global Digital Biomarker Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Digital Biomarker Revenue Market Share by Application (2027–2032)

Table 31. North America Digital Biomarker Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Digital Biomarker Market Size by Country (US$ Million), 2021–2026

Table 33. North America Digital Biomarker Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Digital Biomarker Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Digital Biomarker Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Digital Biomarker Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Digital Biomarker Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Digital Biomarker Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Digital Biomarker Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Digital Biomarker Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Digital Biomarker Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Digital Biomarker Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Digital Biomarker Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Digital Biomarker Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Digital Biomarker Market Size by Country (US$ Million), 2027–2032

Table 46. Philips Company Details

Table 47. Philips Business Overview

Table 48. Philips Digital Biomarker Product

Table 49. Philips Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 50. Philips Recent Development

Table 51. Johnson & Johnson Company Details

Table 52. Johnson & Johnson Business Overview

Table 53. Johnson & Johnson Digital Biomarker Product

Table 54. Johnson & Johnson Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 55. Johnson & Johnson Recent Development

Table 56. Pfizer Company Details

Table 57. Pfizer Business Overview

Table 58. Pfizer Digital Biomarker Product

Table 59. Pfizer Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 60. Pfizer Recent Development

Table 61. GE Healthcare Company Details

Table 62. GE Healthcare Business Overview

Table 63. GE Healthcare Digital Biomarker Product

Table 64. GE Healthcare Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 65. GE Healthcare Recent Development

Table 66. Novartis Company Details

Table 67. Novartis Business Overview

Table 68. Novartis Digital Biomarker Product

Table 69. Novartis Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 70. Novartis Recent Development

Table 71. Apple Company Details

Table 72. Apple Business Overview

Table 73. Apple Digital Biomarker Product

Table 74. Apple Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 75. Apple Recent Development

Table 76. Sanofi Company Details

Table 77. Sanofi Business Overview

Table 78. Sanofi Digital Biomarker Product

Table 79. Sanofi Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 80. Sanofi Recent Development

Table 81. GlaxoSmithKline Company Details

Table 82. GlaxoSmithKline Business Overview

Table 83. GlaxoSmithKline Digital Biomarker Product

Table 84. GlaxoSmithKline Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 85. GlaxoSmithKline Recent Development

Table 86. Bayer Company Details

Table 87. Bayer Business Overview

Table 88. Bayer Digital Biomarker Product

Table 89. Bayer Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 90. Bayer Recent Development

Table 91. Merck Company Details

Table 92. Merck Business Overview

Table 93. Merck Digital Biomarker Product

Table 94. Merck Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 95. Merck Recent Development

Table 96. Abbott Laboratories Company Details

Table 97. Abbott Laboratories Business Overview

Table 98. Abbott Laboratories Digital Biomarker Product

Table 99. Abbott Laboratories Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 100. Abbott Laboratories Recent Development

Table 101. Asahi Kasei Company Details

Table 102. Asahi Kasei Business Overview

Table 103. Asahi Kasei Digital Biomarker Product

Table 104. Asahi Kasei Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 105. Asahi Kasei Recent Development

Table 106. Biogen Company Details

Table 107. Biogen Business Overview

Table 108. Biogen Digital Biomarker Product

Table 109. Biogen Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 110. Biogen Recent Development

Table 111. Koneksa Health Company Details

Table 112. Koneksa Health Business Overview

Table 113. Koneksa Health Digital Biomarker Product

Table 114. Koneksa Health Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 115. Koneksa Health Recent Development

Table 116. Roche Company Details

Table 117. Roche Business Overview

Table 118. Roche Digital Biomarker Product

Table 119. Roche Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 120. Roche Recent Development

Table 121. Huma Therapeutics Company Details

Table 122. Huma Therapeutics Business Overview

Table 123. Huma Therapeutics Digital Biomarker Product

Table 124. Huma Therapeutics Revenue in Digital Biomarker Business (US$ Million), 2021–2026

Table 125. Huma Therapeutics Recent Development

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

Table 129. Authors List of This Report

List of Figures

Figure 1. Digital Biomarker Picture

Figure 2. Global Digital Biomarker Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Digital Biomarker Market Share by Type: 2025 vs 2032

Figure 4. Passive Digital Biomarker Features

Figure 5. Active Digital Biomarker Features

Figure 6. Global Digital Biomarker Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Digital Biomarker Market Share by Application: 2025 vs 2032

Figure 8. Clinical Disease Case Studies

Figure 9. Daily Health Case Studies

Figure 10. Digital Biomarker Report Years Considered

Figure 11. Global Digital Biomarker Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 12. Global Digital Biomarker Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Digital Biomarker Market Share by Region: 2025 vs 2032

Figure 14. Global Digital Biomarker Market Share by Players in 2025

Figure 15. Global Digital Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by Digital Biomarker Revenue in 2025

Figure 17. North America Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 18. North America Digital Biomarker Market Share by Country (2021–2032)

Figure 19. United States Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. Canada Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Europe Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Digital Biomarker Market Share by Country (2021–2032)

Figure 23. Germany Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. France Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. U.K. Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Italy Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Russia Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Ireland Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Asia-Pacific Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Digital Biomarker Market Share by Region (2021–2032)

Figure 31. China Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Japan Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. South Korea Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Southeast Asia Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. India Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Australia & New Zealand Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Latin America Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Digital Biomarker Market Share by Country (2021–2032)

Figure 39. Mexico Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Brazil Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Middle East & Africa Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Digital Biomarker Market Share by Country (2021–2032)

Figure 43. Israel Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Saudi Arabia Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. UAE Digital Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Philips Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 47. Johnson & Johnson Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 48. Pfizer Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 49. GE Healthcare Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 50. Novartis Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 51. Apple Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 52. Sanofi Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 53. GlaxoSmithKline Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 54. Bayer Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 55. Merck Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 56. Abbott Laboratories Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 57. Asahi Kasei Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 58. Biogen Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 59. Koneksa Health Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 60. Roche Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 61. Huma Therapeutics Revenue Growth Rate in Digital Biomarker Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Digital Diagnostics System Market Research Report 2024

Global Brain Biomarker Market Research Report 2024

Global Biomarker Market Research Report 2024

Global Biomarker Detection Systems Market Research Report 2024

Global Cardiac Biomarkers Testing Market Insights Forecast to 2030

Global Digital Medical Platform Market Research Report 2024

Global Digital Health Tracking App Market Research Report 2024

Global Female Digital Health Platform Market Research Report 2024

Global Wearable Biological Sensor Market Insights Forecast to 2030

Global Passive Digital Biomarker Market Research Report 2024

Global Commercializing Biomarkers Market Research Report 2025

Biomarker Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Clinical Biomarker Testing Market Research Report 2024

Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Insights Forecast to 2030

Global Digital Biology Market Research Report 2024

Global Oncology Biomarker Market Insights Forecast to 2030

Global Digital Therapeutics Platforms for Mental Health Market Research Report 2024

Digital Pathology Analytic Market

Global Diagnostic Biomarker Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions